CTRI/2022/04/041903尚未招募未知
A double blind randomized controlled trial to assess the efficacy of Aparajita tablet against Yashtimadhu tablet in mild cognitive impairment
Anjali A0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a) Diagnosed cases of Mild Cognitive Impairment as per DSM V diagnostic criteria.
- •b) Age between 50-70 years.
- •c) Those willing to give written consent.
- •d) Those whose MMSE Score lies between 19-23.
- •e) Those who diagnosed with Type II Diabetes Mellitus.
- •f) No discrimination of gender, religion and economic status.
排除标准
- •a) Subjects who have decline in cognitive functions as a result of trauma, surgery
- •cardiovascular diseases, stroke, thyroid dysfunction, chronic kidney diseases,
- •chronic liver diseases.
- •b) Those having major psychiatric co-morbidities.
研究者
相似试验
已完成
不适用
Safety and efficacy of Ayurvedic Capsule in mild to moderate COVID-19 infection.CTRI/2020/07/026570AMAI Charitable Trust Pune72
已完成
4 期
A randomized double-blind controlled trial to assess the benefits of olanzapine and amisulpride combination treatment in acutely illschizophrenia patients.-COMBINEF20F25Schizoaffective disordersSchizophreniaDRKS00003603niversitätsklinikum Düsseldorf328
已完成
不适用
Benefits of glutamine enriched feed over normal routine feed in traumatic brain injury patients:A double blinded RCTCTRI/2014/02/004399AIIMS30
招募中
Unknown
Effect of donor Intestinal Microbiota Infusion on Thyroid function in patients with subclinical autoimmune Hypothyroidism.NL-OMON23348Amsterdam UMC34
招募中
不适用
A double blind randomized controlled trial to investigate laser acupuncture treatment for smoking cessation.ACTRN12608000050358Dr Christopher Zaslawski120